Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

delamanid

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Delamanid, a bicyclic nitroimidazooxazole, is effective against M. tuberculosis. Previous studies have shown that resistance to a… Expand
Is this relevant?
Highly Cited
2016
Highly Cited
2016
The European Respiratory Journal has recently discussed delamanid and bedaquiline and their use in difficult-to-treat cases… Expand
Is this relevant?
2016
2016
There is an urgent requirement for safe, oral and cost-effective drugs for the treatment of visceral leishmaniasis (VL). We… Expand
Is this relevant?
2016
2016
ABSTRACT Delamanid is a medicinal product approved for treatment of multidrug-resistant tuberculosis. Three studies were… Expand
  • figure 1
  • table 2
  • table 3
  • table 4
  • figure 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to… Expand
Is this relevant?
2015
2015
  • Barbara Rivera
  • The New England journal of medicine
  • 2015
  • Corpus ID: 205120204
Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to… Expand
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Intense search has been made in the discovery of newer anti-TB drugs to tackle the issues such as drug resistance, HIV co… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new antituberculosis medication that inhibits… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Multidrug-resistant and extensively drug-resistant tuberculosis (TB) are associated with worse treatment outcomes for patients… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Delamanid (OPC-67683) is a novel mycolic acid biosynthesis inhibitor active against Mycobacterium tuberculosis at a… Expand
Is this relevant?